Piperidine → Dibenz[b,f]oxepin-10-yl-piperidin-1-yl-methanone
Reaction equation
C(Cl)(=O)C(Cl)=O.[CH:7]1[C:17]2[CH:16]=[C:15]([C:18]([OH:20])=O)[C:14]3[CH:21]=[CH:22][CH:23]=[CH:24][C:13]=3[O:12][C:11]=2[CH:10]=[CH:9][CH:8]=1.[NH:25]1[CH2:30][CH2:29][CH2:28][CH2:27][CH2:26]1.CCN(CC)CC>CN(C)C=O.ClCCl>[CH:7]1[C:17]2[CH:16]=[C:15]([C:18]([N:25]3[CH2:30][CH2:29][CH2:28][CH2:27][CH2:26]3)=[O:20])[C:14]3[CH:21]=[CH:22][CH:23]=[CH:24][C:13]=3[O:12][C:11]=2[CH:10]=[CH:9][CH:8]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
1.1 ml (12.59 mmol) of oxalyl chloride and 1 drop of dimethylformamide are added at room temperature to a solution of 3.0 g is (12.59 mmol) of dibenz[b,f]oxepine-10-carboxylic acid in 20 ml of dichloromethane and the mixture is stirred for 4 hours. 1.86 ml (18.88 mmol) of piperidine and 2.62 ml (18.88 mmol) of Et3N are then added and the mixture is stirred at room temperature overnight. The reaction mixture is washed 1× with hydrochloric acid and brine, and the organic phase is dried, concentrated, subjected to column chromatography and crystallised from tert-butyl methyl ether. 2.64 g (8.6 mmol)=69% of dibenz[b,f]oxepin-10-yl-piperidin-1-yl-methanone are obtained in the form of light-yellow crystals; melting point: 127°-128° C.; 1H-NMR (CDCl3, 200 MHz): 1.30-1.50 (mbr, 2H); 1.50-1.70 (mbr, 4H); 3.30-3.45 (mbr, 2H); 363-3.78 (mbr 2H); 6.92 (s, 1H); 7.10-7.40 (m, 8H); MS: 305 (M+), 221, 193, 165; TLC (silica gel; ethyl acetate/hexane=1:1; UV): Rf =0.32.
Workup
- stirringthe mixture is stirred at room temperature overnight
- washThe reaction mixture is washed 1× with hydrochloric acid and brine
- customthe organic phase is dried
- concentrationconcentrated
- customcrystallised from tert-butyl methyl ether
Sources & evidence
- ORD record
- ord-423a3e8c8f7644cbb1af1e868640aaf9
- Source dataset
- uspto-grants-1998_07
- Patent number
- US05780501
Reaction notes
Loading…